State Requirement Info
Presented by Irina Linkov Middleton, AuD, CCC-A
Presented by Soumit Dasgupta, MD
Presented by Gail Whitelaw, PhD, Abigail Smiles, AuD, Breanna Langenek, BA, Devan Lander, BS, Hailey Long, BA, Theodora Bowman, BA
Presented by Rebecca M. Lewis, AuD, PhD
Presented by Kathleen Muldoon, PhD, Nathan Page, MD, Aditi Bhuskute, MD, Stephanie Browning McVicar, AuD, CCC-A, Stephen L Pedron, MD, MBA, Deborah Flynn, AuD, Alissa Nickerson, AuD, Wendy Steuerwald, AuD, Harold Magalnick, MD, FAAP, Mimi Pruniski, OTR/L, Patrice Jung, MA
Presented by Mimi Pruniski, OTR/L, Patrice Jung, MA
Presented by Harold Magalnick, MD, FAAP, Kathleen Muldoon, PhD
Presented by Deborah Flynn, AuD, Alissa Nickerson, AuD, Wendy Steuerwald, AuD
Presented by Stephen L Pedron, MD, MBA
Presented by Daniel Zeitler, MD, FACS
Searching all 58 courses
1
https://www.audiologyonline.com/audiology-ceus/course/ototoxicity-monitoring-programs-addressing-existing-38807
Ototoxicity Monitoring Programs: Addressing Existing Barriers
This course analyzes current barriers hindering the consistent implementation of effective ototoxicity monitoring programs in the clinical setting. This course also highlights various ways these barriers were able to be addressed and successfully implemented by showcasing existing data.
auditory, textual, visual
Ototoxicity Monitoring Programs: Addressing Existing Barriers
Course: #38807Level: Introductory1 Hour
AAA/0.1 Introductory; ACAud/1.0; AHIP/1.0; ASHA/0.1 Introductory, Professional; BAA/1.0; CAA/1.0; Calif SLPAB/1.0; IACET/0.1; IHS/1.0; Kansas, LTS-S0035/1.0; NZAS/1.0; SAC/1.0; TX TDLR/1.0 Non-manufacturer, TX-142-23-088
This course analyzes current barriers hindering the consistent implementation of effective ototoxicity monitoring programs in the clinical setting. This course also highlights various ways these barriers were able to be addressed and successfully implemented by showcasing existing data.
2
https://www.audiologyonline.com/audiology-ceus/course/auditory-and-vestibular-complications-legalities-38836
Auditory and Vestibular Complications and Legalities Following Head Injuries
Audiovestibular system assessment and management are crucial in head injuries to improve a person’s life. This lecture discusses the pathomechanism, epidemiology, clinical features, and management of audiovestibular injuries following head injuries and the legal perspective with the author’s own extensive case series.
auditory, textual, visual
Auditory and Vestibular Complications and Legalities Following Head Injuries
Course: #38836Level: Advanced2 Hours
AAA/0.2 Advanced; ACAud/2.0; AHIP/2.0; BAA/2.0; CAA/2.0; Calif SLPAB/2.0; IACET/0.2; IHS/2.0; Kansas, LTS-S0035/2.0; NZAS/2.0; SAC/2.0
Audiovestibular system assessment and management are crucial in head injuries to improve a person’s life. This lecture discusses the pathomechanism, epidemiology, clinical features, and management of audiovestibular injuries following head injuries and the legal perspective with the author’s own extensive case series.
3
https://www.audiologyonline.com/audiology-ceus/course/grand-rounds-cases-in-medical-38797
Grand Rounds: Cases in Medical Audiology, presented in partnership with The Ohio State University
This course focuses on cases that incorporate aspects of medical audiology and considerations for audiologists providing patient care in this population.
auditory, textual, visual
Grand Rounds: Cases in Medical Audiology, presented in partnership with The Ohio State University
Course: #38797Level: Advanced1.5 Hours
AAA/0.15 Advanced; ACAud/1.5; ASHA/0.15 Advanced, Professional; BAA/1.5; CAA/1.5; Calif SLPAB/1.5; IACET/0.2; IHS/1.5; Kansas, LTS-S0035/1.5; NZAS/2.0; SAC/1.5
This course focuses on cases that incorporate aspects of medical audiology and considerations for audiologists providing patient care in this population.
4
https://www.audiologyonline.com/audiology-ceus/course/20q-auditory-biotechnologies-38717
20Q: Auditory Biotechnologies - Finding Their Way to the Clinic
This article details the latest developments in the field of auditory biotechnologies that aim to medically treat hearing loss using a series of different approaches. The biotechnologies described in this interview include both restorative and protective treatments, and some of the molecular and cellular mechanisms behind these treatments are described along with the most likely patient populations for early clinical trials. Finally, the current state of offerings for auditory biotechnologies is also reviewed, and readers are pointed to appropriate information to connect their patients to upcoming clinical trials.
textual, visual
20Q: Auditory Biotechnologies - Finding Their Way to the Clinic
Course: #38717Level: Intermediate1 Hour
AAA/0.1 Intermediate; ACAud/1.0; ASHA/0.1 Intermediate, Related; BAA/1.0; CAA/1.0; Calif SLPAB/1.0; IACET/0.1; IHS/1.0; Kansas, LTS-S0035/1.0; NZAS/1.0; SAC/1.0
This article details the latest developments in the field of auditory biotechnologies that aim to medically treat hearing loss using a series of different approaches. The biotechnologies described in this interview include both restorative and protective treatments, and some of the molecular and cellular mechanisms behind these treatments are described along with the most likely patient populations for early clinical trials. Finally, the current state of offerings for auditory biotechnologies is also reviewed, and readers are pointed to appropriate information to connect their patients to upcoming clinical trials.
5
https://www.audiologyonline.com/audiology-ceus/course/congenital-cytomegalovirus-ccmv-what-health-38771
Congenital Cytomegalovirus (cCMV): What Health Care Providers Need to Know Now, in partnership with Midwestern University and Phoenix Children’s Hospital
The congenital CMV (cCMV) series presents the latest research on diagnosis and treatment, raise awareness, delineate prevention efforts, provide information about early intervention options, and disseminate family support resources in an effort to reduce the number of babies infected with cCMV.
auditory, textual, visual
Congenital Cytomegalovirus (cCMV): What Health Care Providers Need to Know Now, in partnership with Midwestern University and Phoenix Children’s Hospital
Course: #38771Level: Advanced7 Hours
AAA/0.7 Advanced; ACAud/7.0; AG Bell - LSLS/7.0 Domain 2, Domain 7; BAA/7.0; CAA/7.0; Calif SLPAB/7.0; IACET/0.7; IHS/7.0; IL EITP/7.0; Kansas, LTS-S0035/7.0; NZAS/3.0; SAC/7.0; Tier 1 (ABA Certificants)/0.7
The congenital CMV (cCMV) series presents the latest research on diagnosis and treatment, raise awareness, delineate prevention efforts, provide information about early intervention options, and disseminate family support resources in an effort to reduce the number of babies infected with cCMV.
6
https://www.audiologyonline.com/audiology-ceus/course/dual-sensory-loss-children-cmv-38750
Understanding the Impact of Dual Sensory Loss in Children with CMV, in partnership with Midwestern University and Phoenix Children's Hospital
This presentation provides an overview of the definition of dual sensory loss and the characteristics of the most common visual deficit – cortical visual impairment (CVI). The impact of early intervention with children with dual sensory impairment are addressed and the value to the family. In addition, important aspects of what to expect from your PCP in dealing with State Agencies when seeking services for a child with CMV are discussed.
auditory, textual, visual
Understanding the Impact of Dual Sensory Loss in Children with CMV, in partnership with Midwestern University and Phoenix Children's Hospital
Course: #38750Level: Advanced1 Hour
AAA/0.1 Advanced; ACAud/1.0; AG Bell - LSLS/1.0 Domain 2, Domain 7; BAA/1.0; CAA/1.0; Calif SLPAB/1.0; IACET/0.1; IHS/1.0; IL EITP/1.0; Kansas, LTS-S0035/1.0; NZAS/1.0; SAC/1.0
This presentation provides an overview of the definition of dual sensory loss and the characteristics of the most common visual deficit – cortical visual impairment (CVI). The impact of early intervention with children with dual sensory impairment are addressed and the value to the family. In addition, important aspects of what to expect from your PCP in dealing with State Agencies when seeking services for a child with CMV are discussed.
7
https://www.audiologyonline.com/audiology-ceus/course/cmv-and-medical-home-in-38756
CMV and the Medical Home, in partnership with Midwestern University and Phoenix Children's Hospital
This course discusses important aspects of what to expect from your PCP when dealing with State Agencies and seeking services for a child with CMV.
auditory, textual, visual
CMV and the Medical Home, in partnership with Midwestern University and Phoenix Children's Hospital
Course: #38756Level: Advanced1 Hour
AAA/0.1 Advanced; ACAud/1.0; AG Bell - LSLS/1.0 Domain 2, Domain 7; BAA/1.0; CAA/1.0; Calif SLPAB/1.0; IACET/0.1; IHS/1.0; IL EITP/1.0; Kansas, LTS-S0035/1.0; NZAS/1.0; SAC/1.0
This course discusses important aspects of what to expect from your PCP when dealing with State Agencies and seeking services for a child with CMV.
8
https://www.audiologyonline.com/audiology-ceus/course/ccmv-essential-knowledge-for-audiologists-38708
cCMV: Essential Knowledge for Audiologists, in partnership with Midwestern University and Phoenix Children's Hospital
cCMV is the most common cause of non-genetic, childhood-onset sensorineural hearing loss, but audiologists are often unaware of it and not trained to provide care to patients who are cCMV positive. This presentation will increase audiologists’ awareness of cCMV and provide practical information on providing care to patients with cCMV.
auditory, textual, visual
cCMV: Essential Knowledge for Audiologists, in partnership with Midwestern University and Phoenix Children's Hospital
Course: #38708Level: Advanced1 Hour
AAA/0.1 Advanced; ACAud/1.0; AG Bell - LSLS/1.0 Domain 2; AHIP/1.0; BAA/1.0; CAA/1.0; Calif SLPAB/1.0; IACET/0.1; IHS/1.0; IL EITP/1.0; Kansas, LTS-S0035/1.0; NZAS/1.0; SAC/1.0
cCMV is the most common cause of non-genetic, childhood-onset sensorineural hearing loss, but audiologists are often unaware of it and not trained to provide care to patients who are cCMV positive. This presentation will increase audiologists’ awareness of cCMV and provide practical information on providing care to patients with cCMV.
9
https://www.audiologyonline.com/audiology-ceus/course/pathophysiology-diagnosis-and-treatment-fetal-38707
Pathophysiology, Diagnosis and Treatment of Fetal CMV, in partnership with Midwestern University and Phoenix Children's Hospital
This course reviews the pathophysiology and treatment of fetal cytomegalovirus.
auditory, textual, visual
Pathophysiology, Diagnosis and Treatment of Fetal CMV, in partnership with Midwestern University and Phoenix Children's Hospital
Course: #38707Level: Advanced1 Hour
AAA/0.1 Advanced; ACAud/1.0; AG Bell - LSLS/1.0 Domain 2; AHIP/1.0; BAA/1.0; CAA/1.0; Calif SLPAB/1.0; IACET/0.1; IHS/1.0; IL EITP/1.0; Kansas, LTS-S0035/1.0; NZAS/1.0; SAC/1.0
This course reviews the pathophysiology and treatment of fetal cytomegalovirus.
10
https://www.audiologyonline.com/audiology-ceus/course/neurotology-for-audiologists-39015
Neurotology for Audiologists
This course discusses various otologic diseases and how audiologists can participate in the care.
auditory, textual, visual
Neurotology for Audiologists
Course: #39015Level: Advanced1 Hour
AAA/0.1 Advanced; ACAud/1.0; AHIP/1.0; ASHA/0.1 Advanced, Professional; BAA/1.0; CAA/1.0; Calif SLPAB/1.0; IACET/0.1; IHS/1.0; Kansas, LTS-S0035/1.0; NZAS/1.0; SAC/1.0
This course discusses various otologic diseases and how audiologists can participate in the care.